Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2007 Jun;99(6):620–626.

The changing profile of esophageal cancer presentation and its implication for diagnosis.

John F Gibbs 1, Ashwani Rajput 1, Krishdeep S Chadha 1, Wade G Douglas 1, Hank Hill 1, Chukwumere Nwogu 1, Hector R Nava 1, Michael S Sabel 1
PMCID: PMC2574377  PMID: 17595930

Abstract

CONTEXT: The incidence of esophageal adenocarcinoma is rising and has surpassed squamous cell carcinoma. OBJECTIVE: To determine how the increasing incidence of esophageal adenocarcinoma alters the classic clinical presentation and the implications of these changes for diagnosis. DESIGN AND SETTING: A five-year retrospective review (1991-1996) was made. PARTICIPANTS: All patients were identified by a computerized registry search with a diagnosis of esophageal carcinoma. MAIN OUTCOME MEASURES: Clinical presentation; duration of symptoms; and correlation with diagnosis, pathology, treatment and outcome. RESULTS: One-hundred-eight (35%) patients had squamous cell carcinoma and 199 (65%) had adenocarcinoma. Dysphagia and weight loss were more common among patients with squamous cell carcinoma (93% and 68%), when compared to adenocarcinoma (79% and 53%). Twenty-one percent of adenocarcinoma patients had other symptoms presentation, including gastroesophageal reflux disease. Once dysphagia was present, there was no correlation between the duration.of symptoms and survival. However, cancers detected in patients who presented with reflux symptoms without dysphagia showed an improved prognosis over patients who presented with both. CONCLUSIONS: Esophageal adenocarcinoma has surpassed squamous cell carcinoma. Gastroesophageal reflux was associated with an earlier stage of presentation compared to the "classic" presentation of esophageal cancer.

Full text

PDF
620

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altorki N. K., Skinner D. B. Adenocarcinoma in Barrett's esophagus. Semin Surg Oncol. 1990;6(5):274–278. doi: 10.1002/ssu.2980060509. [DOI] [PubMed] [Google Scholar]
  2. Blot W. J., Devesa S. S., Fraumeni J. F., Jr Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993 Sep 15;270(11):1320–1320. [PubMed] [Google Scholar]
  3. Cameron A. J., Ott B. J., Payne W. S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med. 1985 Oct 3;313(14):857–859. doi: 10.1056/NEJM198510033131404. [DOI] [PubMed] [Google Scholar]
  4. Chow W. H., Blaser M. J., Blot W. J., Gammon M. D., Vaughan T. L., Risch H. A., Perez-Perez G. I., Schoenberg J. B., Stanford J. L., Rotterdam H. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998 Feb 15;58(4):588–590. [PubMed] [Google Scholar]
  5. Day J. P., Richter J. E. Medical and surgical conditions predisposing to gastroesophageal reflux disease. Gastroenterol Clin North Am. 1990 Sep;19(3):587–607. [PubMed] [Google Scholar]
  6. DeMeester T. R., Barlow A. P. Surgery and current management for cancer of the esophagus and cardia: Part I. Curr Probl Surg. 1988 Jul;25(7):475–531. doi: 10.1016/0011-3840(88)90005-6. [DOI] [PubMed] [Google Scholar]
  7. Hesketh P. J., Clapp R. W., Doos W. G., Spechler S. J. The increasing frequency of adenocarcinoma of the esophagus. Cancer. 1989 Jul 15;64(2):526–530. doi: 10.1002/1097-0142(19890715)64:2<526::aid-cncr2820640228>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  8. Jemal Ahmedin, Siegel Rebecca, Ward Elizabeth, Murray Taylor, Xu Jiaquan, Smigal Carol, Thun Michael J. Cancer statistics, 2006. CA Cancer J Clin. 2006 Mar-Apr;56(2):106–130. doi: 10.3322/canjclin.56.2.106. [DOI] [PubMed] [Google Scholar]
  9. Koshy Mary, Esiashvilli Natia, Landry Jerome C., Thomas Charles R., Jr, Matthews Richard H. Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches. Oncologist. 2004;9(2):137–146. doi: 10.1634/theoncologist.9-2-137. [DOI] [PubMed] [Google Scholar]
  10. Lagergren J., Bergström R., Lindgren A., Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825–831. doi: 10.1056/NEJM199903183401101. [DOI] [PubMed] [Google Scholar]
  11. Martin I. G., Young S., Sue-Ling H., Johnston D. Delays in the diagnosis of oesophagogastric cancer: a consecutive case series. BMJ. 1997 Feb 15;314(7079):467–470. doi: 10.1136/bmj.314.7079.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pera M., Cameron A. J., Trastek V. F., Carpenter H. A., Zinsmeister A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993 Feb;104(2):510–513. doi: 10.1016/0016-5085(93)90420-h. [DOI] [PubMed] [Google Scholar]
  13. Robertson C. S., Mayberry J. F., Nicholson D. A., James P. D., Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus. Br J Surg. 1988 Aug;75(8):760–763. doi: 10.1002/bjs.1800750813. [DOI] [PubMed] [Google Scholar]
  14. Rothwell J. F., Feehan E., Reid I., Walsh T. N., Hennessy T. P. Delay in treatment for oesophageal cancer. Br J Surg. 1997 May;84(5):690–693. [PubMed] [Google Scholar]
  15. Schottenfeld David, Beebe-Dimmer Jennifer. Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin. 2006 Mar-Apr;56(2):69–83. doi: 10.3322/canjclin.56.2.69. [DOI] [PubMed] [Google Scholar]
  16. Solaymani-Dodaran M., Logan R. F. A., West J., Card T., Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut. 2004 Aug;53(8):1070–1074. doi: 10.1136/gut.2003.028076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spechler S. J. Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? Ann Intern Med. 1987 Jun;106(6):902–904. doi: 10.7326/0003-4819-106-6-902. [DOI] [PubMed] [Google Scholar]
  18. Streitz J. M., Jr, Ellis F. H., Jr, Tilden R. L., Erickson R. V. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am J Gastroenterol. 1998 Jun;93(6):911–915. doi: 10.1111/j.1572-0241.1998.00275.x. [DOI] [PubMed] [Google Scholar]
  19. Vaughan T. L., Davis S., Kristal A., Thomas D. B. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):85–92. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES